Literature DB >> 9674651

Obesity, salt intake, and renal perfusion in healthy humans.

L E Porter1, N K Hollenberg.   

Abstract

Renal perfusion rises as obesity develops during short-term overfeeding in animal studies. In humans, the assessment is complicated by the need to normalize renal perfusion for body size. We made use of the fact that radioactive xenon washout measures renal perfusion per unit of tissue mass to address this issue by comparing 45 moderately obese and 147 lean healthy potential kidney donors. All were disease free. The rationale for involving kidney donors reflects the fact that the xenon method for measuring renal perfusion demands injection of the xenon directly into the renal artery, which can be accomplished during the arteriogram that is a necessary part of potential kidney donor evaluation. In 21 obese subjects (body mass index [BMI], 29.1+/-0.9) in balance on a 10-mmol sodium intake, renal perfusion (352+/-16 mL x 100 g(-1) x min(-1)) was significantly higher than predicted from findings in the 95 lean control subjects (313+/-3 mL x 100 g(-1) x min(-1); P=0.035) after adjustment for age. With a high sodium intake (200 mmol), however, renal perfusion was not significantly different in 24 obese subjects (BMI, 28.8+/-0.7; 323+/-13 mL x 100 g(-1) x min(-1)) in comparison to 52 lean controls (341+/-10 mL x 100 g(-1) x min(-1) after adjustment for age. Systolic and diastolic blood pressures were similar in obese and age- and gender-matched lean control subjects. Renal vasodilation was seen in association with sustained obesity in humans. While the mechanisms of obesity-related vasodilation are unclear, the dependence on sodium intake in this study is consistent with a role for the renin-angiotensin system. The findings are not in accordance with a reduction in renal perfusion reported in healthy obese humans in whom measured renal perfusion was indexed for body size.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1998        PMID: 9674651     DOI: 10.1161/01.hyp.32.1.144

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Obesity, blood pressure, and renal sodium handling.

Authors:  M H Weinberger
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 2.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 3.  Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2017-09-30       Impact factor: 2.041

4.  Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease.

Authors:  Shin Young Ahn; Dong Ki Kim; Seung Seok Han; Jung Hwan Park; Sung Joon Shin; Sang Ho Lee; Bum Soon Choi; Chun Soo Lim; Suhnggwon Kim; Ho Jun Chin
Journal:  Kidney Res Clin Pract       Date:  2018-03-31

Review 5.  Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.

Authors:  Stevie Rowe; David Siegel; Daniel K Benjamin
Journal:  Clin Ther       Date:  2015-08-29       Impact factor: 3.637

6.  Pharmacokinetics of Antimicrobials in Obese Children.

Authors:  Mr Sampson; M Cohen-Wolkowiez; Dk Benjamin; Ev Capparelli; Km Watt
Journal:  GaBI J       Date:  2013

7.  Effect of Acetazolamide on Obesity-Induced Glomerular Hyperfiltration: A Randomized Controlled Trial.

Authors:  Boris Zingerman; Michal Herman-Edelstein; Arie Erman; Sarit Bar Sheshet Itach; Yaacov Ori; Benaya Rozen-Zvi; Uzi Gafter; Avry Chagnac
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

8.  Proximal tubular hypertrophy and enlarged glomerular and proximal tubular urinary space in obese subjects with proteinuria.

Authors:  Ana Tobar; Yaacov Ori; Sydney Benchetrit; Gai Milo; Michal Herman-Edelstein; Boris Zingerman; Netta Lev; Uzi Gafter; Avry Chagnac
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

9.  Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: First report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study.

Authors:  Roya Kelishadi; Alaleh Gheissari; Neda Bazookar; Mohammad Esmaeil Motlagh; Mahnaz Taslimi; Gelayol Ardalan
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852

10.  CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress.

Authors:  Seung Joo Lee; Jeong Suk Kang; Hong Min Kim; Eun Soo Lee; Ji-Hye Lee; Choon Hee Chung; Eun Young Lee
Journal:  PLoS One       Date:  2019-09-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.